Fortress Biotech, Inc.

Holdings History for AVENUE THERAPEUTICS, INC. - Common Stock (ATXI)

Symbol: ATXI on OTC
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 439,955 shares
Security Ownership %: 13%

Fortress Biotech, Inc. ownership in AVENUE THERAPEUTICS, INC. Common Stock (ATXI)

06 Jan 2026 - Fortress Biotech, Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 439,955 shares of AVENUE THERAPEUTICS, INC. Common Stock (ATXI). This represents 13% ownership of the company. In their previous filing dated 02 Apr 2025, Fortress Biotech, Inc. had reported owning 328,746 shares, indicating an increase of +34%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Fortress Biotech, Inc.	13%	+31%	$290,370	439,955	+111,209	+34%	$0.66	13D/A	02 Jan 2026	06 Jan 2026, 16:11
Fortress Biotech, Inc.	10%	-25%	$82,186	328,746	+33,724	+11%	$0.25	13D/A	31 Mar 2025	02 Apr 2025, 17:00
Fortress Biotech, Inc.	14%		$73,756	295,022			$0.25	13D/A	31 Dec 2024	03 Jan 2025, 17:50